Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$134.51

0.33 (0.25%)

15:20
09/15/17
09/15
15:20
09/15/17
15:20

J&J's Janssen gets positive opinion from CHMP on guselkumab

Janssen-Cilag International NV announced that the Committee for Medicinal Products for Human Use, CHMP, adopted a positive opinion recommending marketing authorisation in the European Union for the use of guselkumab in the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy. Reference Link

  • 22

    Sep

  • 27

    Sep

  • 17

    Oct

JNJ Johnson & Johnson
$134.51

0.33 (0.25%)

08/02/17
PIPR
08/02/17
NO CHANGE
Target $7
PIPR
Overweight
Imbruvica approval in graft versus host positive for Kadmon, says Piper Jaffray
After the FDA expanded the approval of AbbVie (ABBV) and Johnson & Johnson's (JNJ) Imbruvica for the treatment of adults with chronic graft versus host disease, or cGVHD, Piper Jaffray analyst Edward Tenthoff said he views the news as positive for Kadmon's KD025. Imbruvica is tough for patients to tolerate, said Tenthoff, who sees an opportunity for KD025 to more safely treat cGVHD patients. He keeps an Overweight rating and $7 price target on Kadmon shares.
08/14/17
BTIG
08/14/17
UPGRADE
Target $100
BTIG
Buy
Masimo upgraded to Buy, could be acquired by Johnson & Johnson, says BTIG
BTIG analyst Sean Lavin upgraded Masimo (MASI) to Buy from Neutral with a $100 price target saying he is more bullish on the Philips (PHG) agreement leading to increased revenue and margins, and the recent share pullback has provided a buying opportunity. Lavin said Masimo has been executing "superbly" and believes the Philips' relationship will drive acceptance of hemoglobin and Rainbow. Further, the analyst thinks Johnson & Johnson (JNJ) could be an acquirer of Masimo as it sells its products into the OR and ICU markets and would "massively" expand operating margins, and notes Philips may see the value of Masimo's products and make a bid.
08/16/17
JPMS
08/16/17
NO CHANGE
Target $148
JPMS
Overweight
Johnson & Johnson price target raised ahead of ESC meeting at JPMorgan
JPMorgan analyst Michael Weinstein raised his price target for Johnson & Johnson shares to $148 from $140 ahead of the European Society of Cardiology beginning on August 26. The big event for J&J is the presentation of the COMPASS trial, investigating the use of Xarelto for the treatment of coronary or peripheral artery disease, Weinstein tells investors in a research note. His statistical analysis suggests a minimum 25% reduction in major adverse cardiac events, or MACE. This would make COMPASS a "landmark event in the treatment of CAD/PAD" and lead to Xarelto being adopted as the new standard of care in this greater than $5B indication, Weinstein writes. He recommends buying J&J shares ahead of the European Society of Cardiology meeting and keeps an Overweight rating on the name.
08/31/17
UBSW
08/31/17
NO CHANGE
Target $148
UBSW
Buy
Johnson & Johnson remain a top pick, says UBS
UBS analyst Matt Miksic met with Johnson & Johnson management and came away remaining confident in his conviction of his bullish view on the company. The analyst sees sustained Pharma growth, stable Med Device growth and an improving Consumer division. He identifies multiple drivers, including its pipeline and potential deal interest in Eye Care, Dental, Structural Heart and Neurology. Miksic reiterated his Buy rating and $148 price target on the stock, adding Johnson & Johnson remains a top pick.

TODAY'S FREE FLY STORIES

HUBS

HubSpot

$72.15

-1.75 (-2.37%)

17:47
09/26/17
09/26
17:47
09/26/17
17:47
Earnings
HubSpot raises Q3 EPS view to (4c)-(2c) from (10c)-(8c), consensus (9c) »

Raises Q3 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

CSCO

Cisco

$33.76

0.04 (0.12%)

17:46
09/26/17
09/26
17:46
09/26/17
17:46
Periodicals
Cisco to cut around 310 headquarters jobs, Bloomberg reports »

Cisco is cutting about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

HUBS

HubSpot

$72.15

-1.75 (-2.37%)

17:45
09/26/17
09/26
17:45
09/26/17
17:45
Hot Stocks
Breaking Hot Stocks news story on HubSpot 

HubSpot raises Q3 outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

NKE

Nike

$53.70

0.47 (0.88%)

17:42
09/26/17
09/26
17:42
09/26/17
17:42
Earnings
Nike sees FY18 revenue growth in mid-single digit range, consensus $36.01B »

Sees FY18 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

NKE

Nike

17:41
09/26/17
09/26
17:41
09/26/17
17:41
Earnings
Nike sees Q2 revenue growth in low single digit range, consensus $8.48B »

Sees Q2 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

LLNW

Limelight Networks

$3.80

0.01 (0.26%)

17:36
09/26/17
09/26
17:36
09/26/17
17:36
Conference/Events
Limelight Networks management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 29

    Sep

  • 18

    Oct

  • 14

    Nov

  • 15

    Nov

CTAS

Cintas

$136.10

-0.77 (-0.56%)

, MU

Micron

$34.18

-0.69 (-1.98%)

17:35
09/26/17
09/26
17:35
09/26/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Cintas…

CTAS

Cintas

$136.10

-0.77 (-0.56%)

MU

Micron

$34.18

-0.69 (-1.98%)

EDIT

Editas Medicine

$20.30

-0.83 (-3.93%)

TWTR

Twitter

$16.59

-0.39 (-2.30%)

NKE

Nike

$53.70

0.47 (0.88%)

KRNT

Kornit Digital

$17.15

-0.15 (-0.87%)

WLKP

Westlake Chemical Partners

$24.10

0.15 (0.63%)

ITCI

Intra-Cellular

$19.23

-0.57 (-2.88%)

ASND

Ascendis Pharma

$37.10

0.97 (2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

NKE

Nike

$53.70

0.47 (0.88%)

17:31
09/26/17
09/26
17:31
09/26/17
17:31
Hot Stocks
Nike: North America marketplace still undergoing 'significant' transformation »

Says seeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

BVXV

BiondVax

17:29
09/26/17
09/26
17:29
09/26/17
17:29
Hot Stocks
Breaking Hot Stocks news story on BiondVax »

Eastern Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$53.70

0.47 (0.88%)

17:23
09/26/17
09/26
17:23
09/26/17
17:23
Hot Stocks
Nike 'bullish' on long-term opportunity in North America. »

Says sportswear category…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

OIS

Oil States

$25.75

0.25 (0.98%)

, STL

Sterling Bancorp

$24.10

0.15 (0.63%)

17:22
09/26/17
09/26
17:22
09/26/17
17:22
Hot Stocks
Breaking Hot Stocks news story on Oil States, Sterling Bancorp »

Oil States to replace…

OIS

Oil States

$25.75

0.25 (0.98%)

STL

Sterling Bancorp

$24.10

0.15 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$16.59

-0.39 (-2.30%)

17:21
09/26/17
09/26
17:21
09/26/17
17:21
Hot Stocks
Twitter to begin testing longer 280 character Tweets with small group »

Aliza Rosen, product…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEM

Kemet

, AF

Astoria Financial

$21.09

0.08 (0.38%)

17:21
09/26/17
09/26
17:21
09/26/17
17:21
Hot Stocks
Breaking Hot Stocks news story on Kemet, Astoria Financial »

Kemet to replace Astoria…

KEM

Kemet

AF

Astoria Financial

$21.09

0.08 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

STL

Sterling Bancorp

$24.10

0.15 (0.63%)

, OIS

Oil States

$25.75

0.25 (0.98%)

17:20
09/26/17
09/26
17:20
09/26/17
17:20
Hot Stocks
Sterling Bancorp to repalce Oil States in S&P 400 at open on 10/2 »

Sterling Bancorp (STL) …

STL

Sterling Bancorp

$24.10

0.15 (0.63%)

OIS

Oil States

$25.75

0.25 (0.98%)

AF

Astoria Financial

$21.09

0.08 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$16.59

-0.39 (-2.30%)

17:20
09/26/17
09/26
17:20
09/26/17
17:20
Hot Stocks
Twitter jumps after announcing testing for longer Tweets »

Shares of Twitter are up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.02

0.25 (0.43%)

, PRXL

Parexel

$88.05

0.035 (0.04%)

17:18
09/26/17
09/26
17:18
09/26/17
17:18
Hot Stocks
Six Flags to replace Parexel in S&P 400 at open on 10/2 »

Pamplona Capital…

SIX

Six Flags

$58.02

0.25 (0.43%)

PRXL

Parexel

$88.05

0.035 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

NKE

Nike

17:16
09/26/17
09/26
17:16
09/26/17
17:16
Hot Stocks
Nike says Q1 online sales up 19% »

Says Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

HOMB

Home Bancshares

$24.05

0.28 (1.18%)

, SGBK

Stonegate Bank

$51.62

0.59 (1.16%)

17:11
09/26/17
09/26
17:11
09/26/17
17:11
Hot Stocks
Home Bancshares announces completion of the acquisition of Stonegate Bank »

Home BancShares (HOMB)…

HOMB

Home Bancshares

$24.05

0.28 (1.18%)

SGBK

Stonegate Bank

$51.62

0.59 (1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

TWTR

Twitter

$16.59

-0.39 (-2.30%)

17:11
09/26/17
09/26
17:11
09/26/17
17:11
Hot Stocks
Twitter to begin testing longer 280 character tweets with small group »

Aliza Rosen, product…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMH

American Homes 4 Rent

$22.03

0.04 (0.18%)

17:08
09/26/17
09/26
17:08
09/26/17
17:08
Hot Stocks
American Homes 4 Rent estimates to pay $10M in damage from recent hurricanes »

American Homes 4 Rent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$63.03

0.14 (0.22%)

17:05
09/26/17
09/26
17:05
09/26/17
17:05
Hot Stocks
T-Mobile to acquire remaining interest of iWireless from Aureon »

T-Mobile US announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

ZSAN

Zosano Pharma

$0.79

-0.0498 (-5.93%)

17:04
09/26/17
09/26
17:04
09/26/17
17:04
Hot Stocks
Zosano Pharma provides patent application update »

Zosano Pharma received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELUXY

Electrolux AB

$69.63

-0.2675 (-0.38%)

17:02
09/26/17
09/26
17:02
09/26/17
17:02
Downgrade
Electrolux AB rating change  »

Electrolux AB downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$284.74

3.37 (1.20%)

17:01
09/26/17
09/26
17:01
09/26/17
17:01
Hot Stocks
Northrop Grumman COO Flach to retire, Warden named next COO »

Northrop Grumman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBB

Westbury Bancorp

$20.05

-0.3508 (-1.72%)

17:00
09/26/17
09/26
17:00
09/26/17
17:00
Hot Stocks
Breaking Hot Stocks news story on Westbury Bancorp  »

Westbury Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.